Test4Free.org’s team of providers offer telehealth appointments for consultations regarding COVID 19. The same providers our patients meet during testing/vaccinations at our sites are available to host virtual office visits for follow ups or any questions/concerns relating to COVID 19.
Telehealth visits are now being offered to patients who have tested positive and would like further one on one guidance.
Patients who have not tested positive are also welcomed to schedule a virtual visit for any questions or concerns relating to COVID-19.
Telehealth visits are now being offered to patients who have tested positive and would like further one on one guidance.
Patients who have not tested positive are also welcomed to schedule a virtual visit for any questions or concerns relating to COVID 19.
Click the Request Appointment button where you will be redirected to the scheduling site- Simplybook.me
Once booking has been completed, please be sure your current ID and health insurance information is sent to ID@test4free.org.
Once all information has been received, the appointment will be confirmed and you will receive a Zoom link for a telehealth with a Test4Free provider.
FAQs
Who can request a telehealth appointment?
Anyone with questions or concerns about COVID 19, whether not you are an established patient.
What is a telehealth visit?
A telehealth is a virtual appointment in which a provider and patient will meet in a virtual video call chat room to discuss any matter the patient wishes to discuss regarding COVID 19.
What should I expect during a telehealth visit?
The provider will join the Zoom meeting and allow you into the chatroom at the time of appointment. The provider will address and answer any of your questions or concerns pertaining to the reason for your telehealth visit. They can also offer any guidance on symptom management, vaccinations, etc.
How long is a telehealth visit?
The telehealth visit is as long as a patient needs. However, we do ask it be no longer than 30 minutes as the providers are also seeing patients at the testing sites.
